Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bodal Chemicals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199221-08-2014
21-08-2014
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Shakuntala J Patel has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201121-08-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bodal Chemicals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199220-08-2014
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Shakuntala J Patel has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201118-08-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bodal Chemicals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199216-08-2014
Financial Results & Limited Review for June 30, 2014 (Standalone)
Bodal Chemicals Ltd about the Standalone Financial Results & a copy of the Limited Review Report for the period ended June 30, 2014.30-07-2014
Closure of Trading Window
Bodal Chemicals Ltd has informed BSE that the Meeting of the Board of Directors of the company will be held on July 30, 2014, inter alia, to transact the following business:- To consider and approve Standalone Un-audited Financial Result for the quarter ended on June 30, 2014.Further, Under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 1992 and Bodal Chemicals Ltd's Code of Conduct for Prevention...21-07-2014
Shareholding Pattern For June 30, 2014
Bodal Chemicals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.08-07-2014
Outcome of Board Meeting
Bodal Chemicals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2014, inter alia, has transacted following:1. The Board of Directors has approved revision in managerial remuneration payable to Mr. Suresh J. Patel, Chairman & M.D., Mr. Bhavin S. Patel and Mr. Ankit S. Patel, Executive Directors of the Company as per recommendation and approval of Nomination and Remuneration Committee, subject to approval of members in next General Meeting....28-05-2014